Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dap…
작성자 채식영양
작성일 21-01-01 00:00
조회 0
댓글 0
본문
GB. Bolli, F. Porcellati, P. Lucidi and CG. Fanelli (2021). Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136. Diabetes care, 44(3), e59-e60. https://doi.org/10.2337/dc20-2575
댓글목록 0
등록된 댓글이 없습니다.
